US Stock MarketDetailed Quotes

STOK Stoke Therapeutics

Watchlist
  • 11.430
  • +0.160+1.42%
Close Nov 22 16:00 ET
  • 11.430
  • 0.0000.00%
Post 16:20 ET
605.41MMarket Cap-5495P/E (TTM)

Stoke Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Total revenue
47.94%4.89M
294.72%4.83M
-18.17%4.22M
-29.22%8.78M
-14.26%2.8M
13.87%3.31M
-176.79%-2.48M
71.73%5.15M
12.41M
3.27M
Operating revenue
47.94%4.89M
294.72%4.83M
-18.17%4.22M
-29.22%8.78M
-14.26%2.8M
13.87%3.31M
-176.79%-2.48M
71.73%5.15M
--12.41M
--3.27M
Cost of revenue
Gross profit
Operating expense
14.26%34.9M
11.02%34.17M
9.20%32.59M
5.82%123.55M
6.39%32.39M
1.63%30.54M
8.12%30.78M
7.36%29.84M
35.67%116.76M
24.13%30.44M
Selling and administrative expenses
23.57%12.69M
27.44%13.04M
0.09%10.22M
6.16%41.32M
13.06%10.61M
3.29%10.27M
1.18%10.23M
7.64%10.21M
22.03%38.92M
7.57%9.38M
-General and administrative expense
23.57%12.69M
27.44%13.04M
0.09%10.22M
6.16%41.32M
13.06%10.61M
3.29%10.27M
1.18%10.23M
7.64%10.21M
22.03%38.92M
7.57%9.38M
Research and development costs
9.54%22.21M
2.85%21.14M
13.94%22.37M
5.65%82.23M
3.41%21.78M
0.81%20.27M
11.95%20.55M
7.22%19.63M
43.70%77.84M
33.27%21.06M
Operating profit
-10.17%-30M
11.79%-29.34M
-14.91%-28.37M
-9.98%-114.77M
-8.87%-29.59M
-0.32%-27.23M
-31.79%-33.26M
0.42%-24.69M
-21.25%-104.36M
-10.80%-27.18M
Net non-operating interest income expense
33.72%3.55M
43.94%3.7M
15.36%2.43M
217.36%9.91M
74.92%2.59M
166.43%2.65M
371.88%2.57M
1,922.12%2.1M
2,501.67%3.12M
4,008.33%1.48M
Total other finance cost
-33.72%-3.55M
-43.94%-3.7M
-15.36%-2.43M
-217.36%-9.91M
-74.92%-2.59M
-166.43%-2.65M
-371.88%-2.57M
-1,922.12%-2.1M
-2,501.67%-3.12M
-4,008.33%-1.48M
Other net income (expense)
-31.71%28K
-217.07%-48K
-1,119.05%-428K
-0.60%166K
-2.38%41K
-2.38%41K
-2.38%41K
0.00%42K
19.29%167K
0.00%42K
Other non- operating income (expenses)
-31.71%28K
-217.07%-48K
-1,119.05%-428K
-0.60%166K
-2.38%41K
-2.38%41K
-2.38%41K
0.00%42K
19.29%167K
0.00%42K
Income before tax
-7.69%-26.43M
16.18%-25.7M
-16.98%-26.37M
-3.59%-104.7M
-5.08%-26.96M
6.01%-24.54M
-24.35%-30.65M
8.54%-22.55M
-17.79%-101.07M
-4.94%-25.66M
Income tax
Net income
-7.69%-26.43M
16.18%-25.7M
-16.98%-26.37M
-3.59%-104.7M
-5.08%-26.96M
6.01%-24.54M
-24.35%-30.65M
8.54%-22.55M
-17.79%-101.07M
-4.94%-25.66M
Net income continuous Operations
-7.69%-26.43M
16.18%-25.7M
-16.98%-26.37M
-3.59%-104.7M
-5.08%-26.96M
6.01%-24.54M
-24.35%-30.65M
8.54%-22.55M
-17.79%-101.07M
-4.94%-25.66M
Minority interest income
Net income attributable to the parent company
-7.69%-26.43M
16.18%-25.7M
-16.98%-26.37M
-3.59%-104.7M
-5.08%-26.96M
6.01%-24.54M
-24.35%-30.65M
8.54%-22.55M
-17.79%-101.07M
-4.94%-25.66M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-7.69%-26.43M
16.18%-25.7M
-16.98%-26.37M
-3.59%-104.7M
-5.08%-26.96M
6.01%-24.54M
-24.35%-30.65M
8.54%-22.55M
-17.79%-101.07M
-4.94%-25.66M
Basic earnings per share
14.55%-0.47
33.33%-0.46
-7.55%-0.57
8.46%-2.38
7.69%-0.6
16.67%-0.55
-9.52%-0.69
19.70%-0.53
-11.11%-2.6
1.52%-0.65
Diluted earnings per share
14.55%-0.47
33.33%-0.46
-7.55%-0.57
8.46%-2.38
7.69%-0.6
16.67%-0.55
-9.52%-0.69
19.70%-0.53
-11.11%-2.6
1.52%-0.65
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022
Total revenue 47.94%4.89M294.72%4.83M-18.17%4.22M-29.22%8.78M-14.26%2.8M13.87%3.31M-176.79%-2.48M71.73%5.15M12.41M3.27M
Operating revenue 47.94%4.89M294.72%4.83M-18.17%4.22M-29.22%8.78M-14.26%2.8M13.87%3.31M-176.79%-2.48M71.73%5.15M--12.41M--3.27M
Cost of revenue
Gross profit
Operating expense 14.26%34.9M11.02%34.17M9.20%32.59M5.82%123.55M6.39%32.39M1.63%30.54M8.12%30.78M7.36%29.84M35.67%116.76M24.13%30.44M
Selling and administrative expenses 23.57%12.69M27.44%13.04M0.09%10.22M6.16%41.32M13.06%10.61M3.29%10.27M1.18%10.23M7.64%10.21M22.03%38.92M7.57%9.38M
-General and administrative expense 23.57%12.69M27.44%13.04M0.09%10.22M6.16%41.32M13.06%10.61M3.29%10.27M1.18%10.23M7.64%10.21M22.03%38.92M7.57%9.38M
Research and development costs 9.54%22.21M2.85%21.14M13.94%22.37M5.65%82.23M3.41%21.78M0.81%20.27M11.95%20.55M7.22%19.63M43.70%77.84M33.27%21.06M
Operating profit -10.17%-30M11.79%-29.34M-14.91%-28.37M-9.98%-114.77M-8.87%-29.59M-0.32%-27.23M-31.79%-33.26M0.42%-24.69M-21.25%-104.36M-10.80%-27.18M
Net non-operating interest income expense 33.72%3.55M43.94%3.7M15.36%2.43M217.36%9.91M74.92%2.59M166.43%2.65M371.88%2.57M1,922.12%2.1M2,501.67%3.12M4,008.33%1.48M
Total other finance cost -33.72%-3.55M-43.94%-3.7M-15.36%-2.43M-217.36%-9.91M-74.92%-2.59M-166.43%-2.65M-371.88%-2.57M-1,922.12%-2.1M-2,501.67%-3.12M-4,008.33%-1.48M
Other net income (expense) -31.71%28K-217.07%-48K-1,119.05%-428K-0.60%166K-2.38%41K-2.38%41K-2.38%41K0.00%42K19.29%167K0.00%42K
Other non- operating income (expenses) -31.71%28K-217.07%-48K-1,119.05%-428K-0.60%166K-2.38%41K-2.38%41K-2.38%41K0.00%42K19.29%167K0.00%42K
Income before tax -7.69%-26.43M16.18%-25.7M-16.98%-26.37M-3.59%-104.7M-5.08%-26.96M6.01%-24.54M-24.35%-30.65M8.54%-22.55M-17.79%-101.07M-4.94%-25.66M
Income tax
Net income -7.69%-26.43M16.18%-25.7M-16.98%-26.37M-3.59%-104.7M-5.08%-26.96M6.01%-24.54M-24.35%-30.65M8.54%-22.55M-17.79%-101.07M-4.94%-25.66M
Net income continuous Operations -7.69%-26.43M16.18%-25.7M-16.98%-26.37M-3.59%-104.7M-5.08%-26.96M6.01%-24.54M-24.35%-30.65M8.54%-22.55M-17.79%-101.07M-4.94%-25.66M
Minority interest income
Net income attributable to the parent company -7.69%-26.43M16.18%-25.7M-16.98%-26.37M-3.59%-104.7M-5.08%-26.96M6.01%-24.54M-24.35%-30.65M8.54%-22.55M-17.79%-101.07M-4.94%-25.66M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -7.69%-26.43M16.18%-25.7M-16.98%-26.37M-3.59%-104.7M-5.08%-26.96M6.01%-24.54M-24.35%-30.65M8.54%-22.55M-17.79%-101.07M-4.94%-25.66M
Basic earnings per share 14.55%-0.4733.33%-0.46-7.55%-0.578.46%-2.387.69%-0.616.67%-0.55-9.52%-0.6919.70%-0.53-11.11%-2.61.52%-0.65
Diluted earnings per share 14.55%-0.4733.33%-0.46-7.55%-0.578.46%-2.387.69%-0.616.67%-0.55-9.52%-0.6919.70%-0.53-11.11%-2.61.52%-0.65
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion--------Unqualified Opinion--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data